Pharmaceutical research and developmentManufacturingSalesPharmaceutical manufacturingPharmaceutical salesPharmaceutical research and developmentCell line development servicesClinical trial supportStable supply of pharmaceuticals
Names without a link are companies not yet registered in OpenBizGraph
§05
Network
NETWORK
Loading the relationship graph...
Drag to move · click to open
§06
History
49 EVENTS
1937 (Showa 12): Daiwa Shokai Co., Ltd. was established. Daiwa Shokai Co., Ltd. was founded in Minami Ward, Osaka City (now Higashishinsaibashi, Chuo Ward, Osaka City).
The Dawn of Fuso
On March 25, 1937, Yamato Shokai Co., Ltd. was established in Minami-ku, Osaka (now Higashishinsaibashi, Chuo-ku, Osaka) as a sales company for domestically produced glucose.
Yamato Shokai Co., Ltd. established.
The Imasato Plant was established in Higashimazato, Higashinari-ku, Osaka, marking the company’s entry into pharmaceutical manufacturing, including glucose injection solutions.
1943 (Showa 18): The Imazato Factory was established. The factory was set up in Higashi-Imazato, Higashinari Ward, Osaka City, marking the company's entry into pharmaceutical manufacturing, including glucose injections.
Imazato Factory established.
Vitanone Injection and Sterile Water for Injection.
1946 (Showa 21): Vitanone injections and distilled water for injection were manufactured.
Vitanone injections and distilled water for injection
The company’s 10th anniversary amid the postwar turmoil. Members of the time gather around then-president Kohei Toda in front of the Inari shrine at the Imasato First Plant.
1947 (Showa 22): 10th anniversary celebration. The company's 10th anniversary was celebrated amid the turmoil of the postwar period. Members of the time gather around then-president Kohei Toda in front of the Inari shrine at the Imazato First Factory.
10th anniversary ceremony.
Although the Imasato Plant suffered fire damage when a neighboring house caught fire, operations soon began at the Imasato Second Plant, distinguished by its sawtooth roof.
1948 (Showa 23): Operations began at the Imazato Second Factory. After the Imazato Factory was damaged by a fire that broke out at a neighboring house, the Imazato Second Factory—distinguished by its sawtooth roof—began operations shortly afterward.
Imazato Second Factory begins operations.
The company name was changed to Fuso Pharmaceutical Industries. The Imasato Second Plant office, where the newly adopted company name can be seen.
1949 (Showa 24): Company name changed. The company changed its name to Fuso Pharmaceutical Industries. The Imazato Second Factory office, where the revised company name can be seen.
Company name changed.
Salsobabylon Injection.
1951 (Showa 26): Salsobabilon injections were manufactured.
Salsobabilon injections
A branch office was opened in Okayama (pictured), along with sales offices in Osaka and Tokyo.
1952 (Showa 27): Expansion of sales offices began. A branch office was opened in Okayama (pictured), along with sales offices in Osaka and Tokyo.
Expansion of Sales Offices Begins
The head office was relocated from Higashimazato, Higashinari-ku, Osaka, to the location of the Osaka Sales Office in Doshomachi, Higashi-ku, Osaka (at the time).
1953 (Showa 28): Headquarters relocated to Doshomachi. The headquarters moved from Higashi-Imazato, Higashinari Ward, Osaka City, to the location of the Osaka Sales Office in Doshomachi, Higashi Ward, Osaka City (at the time).
Moved headquarters to Doshomachi
Neocaldramin.
1954 (Showa 29): Neocaldramines were manufactured.
Neocaldramin
The Joto Plant was built and began operations in Morinomiya, Joto-ku, Osaka, with all employees volunteering their labor. The Imasato Plant was closed. The former Osaka Army Arsenal site is visible in the upper part of the photo.
1957 (Showa 32): The Joto Factory was completed. The Joto Factory was built and began operations in Morinomiya, Joto Ward, Osaka City, with all employees contributing their labor. The Imazato Factory was closed.
Joto Factory completed.
Dialysis solution development.
1960 (Showa 35): Development of dialysis solutions began.
Dialysis solution development.
Expansion of production facilities.
1975 (Showa 50): Production facilities were expanded.
Expansion of production facilities
Listed on the First Section of the Tokyo Stock Exchange.
1989 (Showa 64): Listed on the First Section of the Tokyo Stock Exchange.
Listed on the First Section of the Tokyo Stock Exchange.
Shift to powdered dialysis agents.
2000 (Heisei 12): Switched to powder-form dialysis agents.
Transition to powdered dialysis solution
Transition to the Prime Market.
2019 (Reiwa 1): Moved to the Prime Market.
Transition to the Prime Market
§07
News
2 ARTICLES
Fuso Pharmaceutical Industries Receives Asia Dialysis Drug Development Company Award
Fuso Pharmaceutical Industries Ltd. was selected as the "Dialysis Drug Development Company of the Year in Asia 2026" by Pharma Tech Outlook APAC. The company's efforts and achievements in dialysis medical care were highly evaluated. Details are featured in the profile article of the magazine.
Fuso Pharmaceutical Industry Opens Official X Account
Fuso Pharmaceutical Industry Co., Ltd. has established an official X account to disseminate timely information. Through this, they plan to broadly communicate their activities and employees' thoughts.
§08
Public records
GOV
National Tax Agency basic information5120001077541
Source: National Tax Agency Corporate Number Publication Site, basic three items
Trade name
扶桑薬品工業株式会社
Trade name (kana)
フソウヤクヒンコウギョウ
Name in English
Corporation type
301
Address
〒541-0045 大阪府大阪市中央区道修町1丁目7番10号
Postal code
5410045
Prefecture code
27
City code
128
Address outside Japan
Prefecture in English
City in English
Address outside Japan in English
Corporate number assignment date
2015-10-05
Update date
2018-07-13
Change date
2015-10-05
Registry closure date
Reason for registry closure
Successor corporate number
Details of the change
Latest record
1
Excluded from search
0
Processing type
01
Correction type
1
Trade name image ID
Address image ID
Sequence number
4201380
METI gBizINFO5120001077541
Source: gBizINFO (Ministry of Economy, Trade and Industry)